Evidence map›Paper›PMID 40959395›Full record

ArticleChemical science2025

Maleic anhydride derived diphosphines: adaptable chelators for receptor-targeted

Rachel E Nuttall, Ingebjørg N Hungnes, Truc T Pham, Oliver W L Carter, Alex Rigby, Natasha Patel, Zilin Yu, Julie Cleaver, Jennifer D Young, Gary J R Cook and 6 more

Abstract read
In one paragraph

Article in Chemical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Rachel E NuttallSchool of Bioengineering and Imaging Sciences, King's College London 4th Floor Lambeth Wing, St Thomas' Hospital London SE1 7EH UK rachel.nuttall@kcl.ac.uk michelle.ma@kcl.ac.uk.ORCID https://orcid.org/0000-0002-3945-3096
Ingebjørg N HungnesSchool of Bioengineering and Imaging Sciences, King's College London 4th Floor Lambeth Wing, St Thomas' Hospital London SE1 7EH UK rachel.nuttall@kcl.ac.uk michelle.ma@kcl.ac.uk.
Truc T PhamSchool of Bioengineering and Imaging Sciences, King's College London 4th Floor Lambeth Wing, St Thomas' Hospital London SE1 7EH UK rachel.nuttall@kcl.ac.uk michelle.ma@kcl.ac.uk.ORCID https://orcid.org/0000-0001-5850-4592
Oliver W L CarterSchool of Bioengineering and Imaging Sciences, King's College London 4th Floor Lambeth Wing, St Thomas' Hospital London SE1 7EH UK rachel.nuttall@kcl.ac.uk michelle.ma@kcl.ac.uk.ORCID https://orcid.org/0000-0001-5342-2168
Alex RigbySchool of Bioengineering and Imaging Sciences, King's College London 4th Floor Lambeth Wing, St Thomas' Hospital London SE1 7EH UK rachel.nuttall@kcl.ac.uk michelle.ma@kcl.ac.uk.ORCID https://orcid.org/0000-0003-2221-1602
Natasha PatelSchool of Bioengineering and Imaging Sciences, King's College London 4th Floor Lambeth Wing, St Thomas' Hospital London SE1 7EH UK rachel.nuttall@kcl.ac.uk michelle.ma@kcl.ac.uk.
Zilin YuSchool of Bioengineering and Imaging Sciences, King's College London 4th Floor Lambeth Wing, St Thomas' Hospital London SE1 7EH UK rachel.nuttall@kcl.ac.uk michelle.ma@kcl.ac.uk.ORCID https://orcid.org/0000-0001-6490-0081
Julie CleaverCentre for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre Charterhouse Square London EC1M 6BQ UK.
Jennifer D YoungSchool of Bioengineering and Imaging Sciences, King's College London 4th Floor Lambeth Wing, St Thomas' Hospital London SE1 7EH UK rachel.nuttall@kcl.ac.uk michelle.ma@kcl.ac.uk.ORCID https://orcid.org/0000-0002-4141-9663
Gary J R CookSchool of Bioengineering and Imaging Sciences, King's College London 4th Floor Lambeth Wing, St Thomas' Hospital London SE1 7EH UK rachel.nuttall@kcl.ac.uk michelle.ma@kcl.ac.uk.ORCID https://orcid.org/0000-0002-8732-8134
Lefteris LivieratosSchool of Bioengineering and Imaging Sciences, King's College London 4th Floor Lambeth Wing, St Thomas' Hospital London SE1 7EH UK rachel.nuttall@kcl.ac.uk michelle.ma@kcl.ac.uk.ORCID https://orcid.org/0009-0009-2156-8889
Jane SosabowskiCentre for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre Charterhouse Square London EC1M 6BQ UK.
Hong Hoi TingOncobeta GmbH 85748 Garching Munich Germany.ORCID https://orcid.org/0000-0002-0526-9549
Nicholas VetterOncobeta GmbH 85748 Garching Munich Germany.
Paul G PringleSchool of Chemistry, University of Bristol Cantock's Close Bristol BS8 1TS UK.ORCID https://orcid.org/0000-0001-7250-4679
Michelle T MaSchool of Bioengineering and Imaging Sciences, King's College London 4th Floor Lambeth Wing, St Thomas' Hospital London SE1 7EH UK rachel.nuttall@kcl.ac.uk michelle.ma@kcl.ac.uk.ORCID https://orcid.org/0000-0002-3349-7346

Funding

Wellcome Trust
6 · The paper itself

Abstract

The diagnostic imaging radionuclide,

Identifiers

PMID40959395
PMCPMC12435366

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.